IGF2BP3 and hepatocellular carcinoma: In our pursuit to comprehend the molecular mechanisms by which NC impedes HCC progression post-downregulation of IGF2BP3, we amalgamated IGF2BP3-centric RNA immunoprecipitation sequencing (RIP-seq), real-time quantitative polymerase chain reaction (RT-qPCR), and other bioinformatic methods, and found that metabolic pathways and associated genes may play a significant role in this context.